77 related articles for article (PubMed ID: 3198233)
21. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity.
Kirk GD; Turner PC; Gong Y; Lesi OA; Mendy M; Goedert JJ; Hall AJ; Whittle H; Hainaut P; Montesano R; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):373-9. PubMed ID: 15734960
[TBL] [Abstract][Full Text] [Related]
22. Aflatoxin, a human carcinogen: determination in foods and biological samples by monoclonal antibody affinity chromatography.
Groopman JD; Donahue KF
J Assoc Off Anal Chem; 1988; 71(5):861-7. PubMed ID: 3235405
[TBL] [Abstract][Full Text] [Related]
23. [Immunological detection of aflatoxin-albumin adducts in children with chronic hepatitis B infection].
Alvarez MT; Castañeda C; Ruisanchez N; Aleaga M; García E; Escobar MP
G E N; 1995; 49(1):36-41. PubMed ID: 8566671
[TBL] [Abstract][Full Text] [Related]
24. Detection in human cells of alkylated macromolecules attributable to exposure to nitrosamines.
Montesano R; Brésil H; Degan P; Martel-Planche G; Serres M; Wild CP
IARC Sci Publ; 1988; (89):75-82. PubMed ID: 3198234
[TBL] [Abstract][Full Text] [Related]
25. Etiology of hepatocellular carcinoma in Africa.
Olweny CL
IARC Sci Publ; 1984; (63):89-95. PubMed ID: 6100289
[TBL] [Abstract][Full Text] [Related]
26. Pilot survey of aflatoxin-albumin adducts in sera from Egypt.
Turner PC; Loffredo C; Kafrawy SE; Ezzat S; Eissa SA; Daly ME; Nada O; Abdel-Hamid M
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2008 May; 25(5):583-7. PubMed ID: 18473213
[TBL] [Abstract][Full Text] [Related]
27. Human exposure to aflatoxins in Zimbabwe.
Nyathi CB; Mutiro CF; Hasler JA; Chetsanga CJ
Cent Afr J Med; 1989 Dec; 35(12):542-5. PubMed ID: 2485709
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
[TBL] [Abstract][Full Text] [Related]
29. [Detection of aflatoxin-albumin adducts in human serum and its application].
Sun G; He X; Qian G; Pu Y
Wei Sheng Yan Jiu; 2001 May; 30(3):185-8. PubMed ID: 12525098
[TBL] [Abstract][Full Text] [Related]
30. Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.
Han Y; Tang Q; Zhu W; Zhang X; You L
J Gastroenterol Hepatol; 2008 Nov; 23(11):1728-33. PubMed ID: 18823435
[TBL] [Abstract][Full Text] [Related]
31. The formation of AFB(1)-macromolecular adducts in rats and humans at dietary levels of exposure.
Cupid BC; Lightfoot TJ; Russell D; Gant SJ; Turner PC; Dingley KH; Curtis KD; Leveson SH; Turteltaub KW; Garner RC
Food Chem Toxicol; 2004 Apr; 42(4):559-69. PubMed ID: 15019179
[TBL] [Abstract][Full Text] [Related]
32. Genomic aberrations in human hepatocellular carcinomas of differing etiologies.
Wong N; Lai P; Pang E; Fung LF; Sheng Z; Wong V; Wang W; Hayashi Y; Perlman E; Yuna S; Lau JW; Johnson PJ
Clin Cancer Res; 2000 Oct; 6(10):4000-9. PubMed ID: 11051249
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
34. 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.
Kirk GD; Lesi OA; Mendy M; Szymañska K; Whittle H; Goedert JJ; Hainaut P; Montesano R
Oncogene; 2005 Sep; 24(38):5858-67. PubMed ID: 16007211
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand.
Kuang SY; Lekawanvijit S; Maneekarn N; Thongsawat S; Brodovicz K; Nelson K; Groopman JD
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):380-4. PubMed ID: 15734961
[TBL] [Abstract][Full Text] [Related]
36. Time-resolved fluoroimmunoassay of aflatoxins.
Degan P; Montagnoli G; Wild CP
Clin Chem; 1989 Dec; 35(12):2308-10. PubMed ID: 2591047
[TBL] [Abstract][Full Text] [Related]
37. The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4.
Lee YI; Lee S; Lee Y; Bong YS; Hyun SW; Yoo YD; Kim SJ; Kim YW; Poo HR
Oncogene; 1998 May; 16(18):2367-80. PubMed ID: 9620554
[TBL] [Abstract][Full Text] [Related]
38. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts.
Yu MW; Lien JP; Liaw YF; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice.
Ghebranious N; Sell S
Hepatology; 1998 Feb; 27(2):383-91. PubMed ID: 9462635
[TBL] [Abstract][Full Text] [Related]
40. Hepatocellular carcinoma and infections with multiple hepatitis viruses.
Brunetto MR; Oliveri F; Colombatto P; Bonino F
Princess Takamatsu Symp; 1995; 25():61-6. PubMed ID: 8875610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
